Wells Fargo & Company Cor Medix Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Cor Medix Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 17,981 shares of CRMD stock, worth $83,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,981
Previous 15,758
14.11%
Holding current value
$83,611
Previous $59,000
28.81%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CRMD
# of Institutions
97Shares Held
17.1MCall Options Held
92.9KPut Options Held
293K-
Black Rock Inc. New York, NY3.49MShares$16.2 Million0.0% of portfolio
-
Nomura Holdings Inc Tokyo, M02.95MShares$13.7 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.93MShares$13.6 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$7.21 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$5.5 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $192M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...